在胰腺癌中的表观遗传治疗策略
Arturo Orlacchio1, Stephen Muzyka1, Tamas A Gonda1
1Division of Gastroenterology and Hepatology, New York University, New York, NY, United States.
International review of cell and molecular biology
|February 15, 2024
概括
胰腺管道腺癌 (PDAC) 是一种致命的癌症,由于瘤异质性,治疗方法有限. 表观遗传药物在克服这种异质性和改善治疗反应方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 胰腺管腺癌 (PDAC) 是一种高度致命的恶性瘤,预后不佳,治疗选择有限.
- 由表观遗传调节器驱动的瘤异质性对PDAC的攻击性和对治疗的抵抗性有显著的贡献.
- PDAC中的瘤微环境具有免疫抑制作用,进一步阻碍了有效的治疗方法.
研究的目的:
- 审查PDAC的表观遗传治疗策略的现状.
- 讨论表观遗传疗法如何克服分子和细胞瘤异质性.
- 探索表观遗传药物在改善PDAC治疗反应方面的潜力.
主要方法:
- 对PDAC中的表观遗传药物进行的临床前和临床研究的审查.
- 对表观遗传调节器在PDAC异质性中的作用的分析.
- 评估表观遗传疗法对瘤微环境和药物敏感性的影响.
主要成果:
- 表观遗传药物在PDAC模型中显示出有希望的临床前疗效.
- 这些药物可以使癌细胞对传统的细胞毒性疗法产生敏感性.
- 表观遗传策略显示出对抗免疫抑制PDAC瘤微环境的潜力.
结论:
- 表观遗传疗法具有显著的潜力,可以改善胰腺管道腺癌的治疗结果.
- 进一步的研究和临床试验至关重要,以充分实现表观遗传药物在PDAC管理中的好处.
- 通过表观遗传调制来解决瘤异质性是未来PDAC疗法的关键策略.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:37Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
01:29Chronic Pancreatitis II: Collaborative Care
90
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
90
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K